China YCT International Group Inc. announced unaudited consolidated earnings results for the second quarter and six months ended September 30, 2017. For the quarter, the company reported sales was $13,866,784 against $11,594,484 a year ago. Income from operations was $3,042,956 against $2,634,877 a year ago. Income before income tax provision was $3,074,155 against $2,651,604 a year ago. Net income attributable to the company was $2,236,448 against $1,995,700 a year ago. Basic and diluted earnings per share were $0.08 against $0.07 a year ago. The increase in total Revenue was related to the increase in sales of healthcare products and Huoliyuan capsules and partially offset by a decrease in sales of acer truncatum bunge seed oil. The increase in net income was mainly due to the higher revenues from sales of healthcare products and Huoliyuan capsules as well as lower research and development expenses. For the six months, the company reported sales was $31,001,649 against $21,306,979 a year ago. The increase in total Revenue was across all product categories. Income from operations was $7,681,598 against $4,767,714 a year ago. The increase in total operating income was mainly a result of increased gross profit. Income before income tax provision was $8,310,992 against $4,799,863 a year ago. Net income attributable to the company was $6,046,247 against $3,571,235 a year ago. Basic and diluted earnings per share were $0.20 against $0.12 a year ago. The increase in net income was mainly due to the higher revenues across all product categories, lower research and development expenses and gain from disposal of acer truncatum bunge plants this year. Net cash provided by operating activities was $10,740,623 against $4,937,590 a year ago. Acquisition of property, plant and equipment was $2,110,189 against $1,391,163 a year ago.